Precision Medicine News and Research

RSS

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

BioFortis today announced that Children's Cancer Institute has licensed Labmatrix, the award-winning precision medicine and biobanking software platform, to support their "Zero Childhood Cancer" program.

4 Nov 2015

Resistance to CD19 CAR T-cell therapy can be caused by CD19 splicing alterations

Resistance to CD19 CAR T-cell therapy, a type of immunotherapy that yields long-lasting remissions in many patients with B-cell leukemia, can be caused by CD19 splicing alterations, leading to loss of certain parts of the CD19 protein that are recognized by the CAR T cells.

31 Oct 2015

Mount Sinai researchers provide a glimpse of precision medicine in action

A new publication from scientists at the Icahn School of Medicine at Mount Sinai offers a glimpse of precision medicine in action, with a massive data analysis project that identified clinically and genetically distinct subtypes of patients with type 2 diabetes. This work not only points to the possibility for more tailored diagnosis and treatment of type 2 diabetes in the future, but also reveals a novel approach that can be applied to virtually any disease.

29 Oct 2015

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

The ‘two week wait’ referral was brought into England in 2000. If a patient goes to see their GP and they meet specific criteria that cause the GP to think they might have cancer, then they should be referred to see a specialist within two weeks.

28 Oct 2015

Scientists present alternative method for using significant variables to make useful predictions

Scientists at Columbia University, the University of California, San Diego (UCSD) and Harvard University have presented an alternative method to address the challenge of using significant variables to make useful predictions in areas such as complex disease.

27 Oct 2015

New approaches to treating lung cancer patients in New Mexico

This year, more than 158,000 Americans are expected to die from lung cancer. That's a staggering number: it's more than all the deaths expected from breast, prostate, colon, rectum, bladder and skin cancers combined.

26 Oct 2015

Successful treatment of rare neurodegenerative disease exemplifies potential of precision medicine

A 20-month-old girl suffering from a rare neurodegenerative disease was diagnosed by exome sequencing and successfully treated.

23 Oct 2015

University of Warwick, SYSUCC sign MoU to create cancer research partnership

The University of Warwick and Sun Yat-sen University Cancer Center have signed a Memorandum of Understanding (MoU) to create a research partnership in cancer diagnosis and specialist cancer care.

22 Oct 2015

Quest Diagnostics announces net income of $342 million for third quarter of 2015

Quest Diagnostics Incorporated, the world's leading provider of diagnostic information services, announced today that for the quarter ended September 30, 2015, adjusted net income was $172 million compared to $161 million for 2014. Adjusted diluted EPS excluding amortization was $1.28 in the third quarter of 2015, compared to $1.20 in 2014.

From Quest Diagnostics 22 Oct 2015

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

Luminex Corporation today announced that it has received CE-IVD marking for its NxTAG Respiratory Pathogen Panel. The Panel detects 21 clinically-relevant viral and bacterial respiratory pathogens, including the atypical bacteria Chlamydophila pneumoniae, Mycoplasma pneumoniae, and Legionella pneumophila.

19 Oct 2015

More research needed on commercially available nutrigenomics tests: Study

There is insufficient scientific evidence to support the utility of commercially available nutrigenomics tests that claim to link genetic variants to dietary intake or nutrition-related disorders.

19 Oct 2015

NYSCF, CBR collaborate to customize creation of high-quality stem cell lines

The New York Stem Cell Foundation and Cbr Systems, Inc. DBA Cord Blood Registry today announced a collaboration to customize the creation of high-quality stem cell lines. NYSCF will create induced pluripotent stem (iPS) cell lines from umbilical cord tissue collected after birth from healthy newborns provided by CBR.

19 Oct 2015

OHSU designs new iPhone app to advance melanoma research

Oregon Health & Science University today released an iPhone app designed to advance melanoma research by giving users the ability to accurately measure and monitor moles, and contribute photos of how their potential trouble spots evolve over time.

16 Oct 2015

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

GenomOncology today announced that UCLA Health has adopted the GO Clinical Workbench to accelerate analysis and reporting for its tumor DNA profiling tests.

13 Oct 2015

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

Eli Lilly and Company and ImaginAb Inc. are pleased to announce a preclinical research collaboration to study potential novel T-cell-based immuno-oncology therapies.

13 Oct 2015

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Today, GENALICE is setting a new standard for ultra-fast and highly reliable detection of all DNA changes in large patient cohorts. In a one-hour online event, the complete genomes of 800 Alzheimer Disease (AD) patients were processed, and by ingeniously using the aggregate information from the complete group, detection of DNA changes, or variants, in individual patients was enhanced.

13 Oct 2015

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

13 Oct 2015

Study: RNA editing technique shows promise in treating rare, severe form of muscular dystrophy

An RNA editing technique called "exon skipping" has shown preliminary success in treating a rare and severe form of muscular dystrophy that currently has no treatment, based on a new study from Northwestern Medicine and the University of Chicago. Children with the disease lose significant muscle strength early in life.

13 Oct 2015

Study explains why anemia is a common side effect of anti-cancer drugs

Many types of leukemia are caused by loss of enzymes such as Pten, which normally keeps cell growth in check, or conversely, the over-activation of enzymes that normally enhance cell proliferation, such as Shp2.

13 Oct 2015

Scientists calculate precise measurements of heritability in nine pediatric-onset autoimmune diseases

Scientists have calculated more precise measurements of heritability--the influence of underlying genes--in nine autoimmune diseases that begin in childhood. The research may strengthen researchers' abilities to better predict a child's risk for associated autoimmune diseases.

9 Oct 2015

Precision Medicine News and Research

Children's Cancer Institute licenses Labmatrix to support 'Zero Childhood Cancer' program

Resistance to CD19 CAR T-cell therapy can be caused by CD19 splicing alterations

Mount Sinai researchers provide a glimpse of precision medicine in action

Cancer diagnosis improvements in England: an interview with Lucy Elliss-Brookes

Scientists present alternative method for using significant variables to make useful predictions

New approaches to treating lung cancer patients in New Mexico

Successful treatment of rare neurodegenerative disease exemplifies potential of precision medicine

University of Warwick, SYSUCC sign MoU to create cancer research partnership

Quest Diagnostics announces net income of $342 million for third quarter of 2015

Luminex's NxTAG Respiratory Pathogen Panel receives CE-IVD marking

More research needed on commercially available nutrigenomics tests: Study

NYSCF, CBR collaborate to customize creation of high-quality stem cell lines

OHSU designs new iPhone app to advance melanoma research

UCLA Health adopts GenomOncology's GO Clinical Workbench to accelerate analysis for tumor DNA profiling tests

Lilly, ImaginAb partner to study potential novel T-cell-based immuno-oncology therapies

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

GENALICE’s Population Calling analysis module improves diagnosis, treatment of complex DNA diseases

Study: RNA editing technique shows promise in treating rare, severe form of muscular dystrophy

Study explains why anemia is a common side effect of anti-cancer drugs

Scientists calculate precise measurements of heritability in nine pediatric-onset autoimmune diseases

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News